| Article | Added |
|---|
| U.S. Senate passes bipartisan FDA funding bill | 05-24-12 |
| Mylan settles patent suit over Sunovion's lung drug | 05-24-12 |
| FDA panel votes against Pfizer rare disease drug | 05-24-12 |
| Onyx rises on analyst view of blood cancer drug | 05-24-12 |
| Screening finds skin cancer, but does it save lives? | 05-24-12 |
| Theravance licenses antibiotic tech to Hospira | 05-24-12 |
| Muslim leaders enlisted to help stamp out polio | 05-24-12 |
| Watson Pharma rises on Wells Fargo analyst upgrade | 05-24-12 |
| Feigning injury could risk lives, says referee | 05-24-12 |
| Soy supplement shows no blood pressure benefit | 05-24-12 |
| Anti-obesity proposal fails again at McDonald's | 05-24-12 |
| MediciNova asthma drug fails trial; shares crash | 05-24-12 |
| Missouri opts for untested drug for executions | 05-24-12 |
| Novo obesity drug seen with 43 percent chance of approval | 05-24-12 |
| For Hospitals and Insurers, New Fervor to Cut Costs | 05-24-12 |
| Auxilium sues Watson on testosterone gel patent | 05-24-12 |
| Obesity not always tied to higher heart risk: study | 05-24-12 |
| Hand deformities turn up in poultry workers: report | 05-24-12 |
| The Science Behind Sleep | 05-24-12 |
| Sanofi to test cancer-starving compound in China in 2013 | 05-24-12 |
| Child addicts at heart of Indonesia anti-smoking suit | 05-24-12 |
| U.S. advisers reject J&J/Bayer's Xarelto for acute coronary patients | 05-24-12 |
| Celldex breast cancer drug shrinks some tumors: study | 05-23-12 |
| US advisers reject J&J/Bayer's Xarelto for acute coronary patients | 05-24-12 |
| U.S FDA advisers rebuff J&J/Bayer Xarelto heart drug | 05-23-12 |
| Too many people get angioplasties, study suggests | 05-23-12 |
| Long-term contraception more effective than pills | 05-23-12 |
| Childhood cancer effects may linger in adults | 05-23-12 |
| Nektar rises as analyst evaluates pipeline | 05-23-12 |
| NBC-WSJ Poll: Obama-Romney in Tight Race | 05-23-12 |
| Pfizer emerging markets head leaving for PPD | 05-23-12 |
| Mesa Laboratories 4Q profit little changed | 05-23-12 |
| Miracle sweetener stevia may have a sour note | 05-23-12 |
| Docs win most malpractice suits, but road is long | 05-23-12 |
| Sanofi: No 'Patent Cliff' Expected for Rest of the Decade | 05-22-12 |
| Neurosearch denies share manipulation charges | 05-23-12 |
| Australia says big tobacco aiding WTO challengers | 05-23-12 |
| Sanofi: Not Much Of A Patent Cliff To The Rest of The Decade | 05-22-12 |
| Death rate drops among Americans with diabetes -CDC | 05-22-12 |
| Exercise tied to lower risk of psoriasis: study | 05-22-12 |
| Mom's excess pounds key in newborn weight | 05-22-12 |
| Many babies with development delays may go untreated | 05-22-12 |
| Folic acid tied to lower child cancer risks | 05-22-12 |
| Internet domain name project relaunches after software bug | 05-22-12 |
| U.S. says drug abuse needs treatment, not just jail | 05-22-12 |
| InterMune agrees to sell immune drug Actimmune | 05-22-12 |
| Cardiovascular Systems raises $15M from stock sale | 05-22-12 |
| Merck CEO: Generics, economy to make 2012-13 tough | 05-22-12 |
| Takeda drug impresses in ulcerative colitis study | 05-22-12 |
| Smithsonian to create its 1st human genome exhibit | 05-22-12 |
| Eli Lilly's diabetes drug meets mid-stage trial goal | 05-22-12 |
| Medtronic fiscal 4Q profit climbs 28 pct | 05-22-12 |
| Novo Nordisk diabetes drug gets broader approval | 05-22-12 |
| FDA staff shoots down Pfizer rare disease drug | 05-22-12 |
| Bavarian Nordic says U.S. backs new Imvamune study | 05-22-12 |
| Dos and Don?ts of Working After Retirement | 05-22-12 |
| Ramadan sets Muslim athletes extra test at London Games | 05-22-12 |
| Option Bulls Think Health Care Has a Pulse | 05-22-12 |
| Bayer, Onyx cancer drug fails in late-stage study | 05-22-12 |
| U.S. Catholic groups sue to block contraception mandate | 05-21-12 |
| Fake drugs threaten gains made in war on malaria | 05-21-12 |
| Lung cancer tests advised for some heavy smokers | 05-21-12 |
| Tired surgical residents may up error risk: study | 05-21-12 |
| U.S. task force: End routine prostate cancer screening | 05-21-12 |
| "Pre-diabetes," diabetes rising among U.S. teens | 05-21-12 |
| Not all ICUs need a specialist at night: study | 05-21-12 |
| FDA says Xarelto reduced deadly heart attacks | 05-21-12 |
| FDA staff sends mixed message on Johnson & Johnson drug Xarelto | 05-21-12 |
| Peregrine soars as cancer drug meets trial goal | 05-21-12 |
| "Pre-diabetes,"' diabetes rising among U.S. teens | 05-21-12 |
| Georgia flesh-eating bacteria patient breathing on own: father | 05-21-12 |
| FDA staff sends mixed message on J&J drug Xarelto | 05-21-12 |
| Sigmoidoscopy an option for colon cancer screening | 05-21-12 |
| Missing data raise doubts on J&J drug-US FDA staff | 05-21-12 |
| DaVita to buy HealthCare Partners in $4.42B deal | 05-21-12 |
| Blasting music tied to drinking and drugs: study | 05-21-12 |
| U.S. FDA staff cite missing data for J&J's Xarelto | 05-21-12 |
| Fending off fitness fatigue | 05-21-12 |
| Asia stocks mixed after G8 vague on Europe fix | 05-21-12 |
| Georgia woman with flesh-eating disease in "critical" condition | 05-19-12 |
| The Next Zuckerberg? | 05-18-12 |
| Antibiotics prevent UTIs better than probiotics | 05-18-12 |
| Watson files to launch generic birth control pill | 05-18-12 |
| Health secretary urges contraception compromise | 05-18-12 |
| California teens eat fewer calories in school | 05-18-12 |
| Fish oil shows little effect on Tourette's tics | 05-18-12 |
| Sequenom falls after losing coverage for test | 05-18-12 |
| All baby boomers should get hepatitis C test: CDC | 05-18-12 |
| All baby boomers should get hepatitis C test -CDC | 05-18-12 |
| Span-America raises dividend by 13 percent | 05-18-12 |
| Exclusive: Drugmakers weigh emergency supply plan for Greece | 05-18-12 |
| GSK melanoma drug shows promise in early trial | 05-18-12 |
| New York judge with cancer makes case for marijuana | 05-17-12 |
| Osiris stem cell therapy approved in Canada | 05-17-12 |
| South Carolina woman battles flesh-eating bacterial disease | 05-17-12 |
| Fewer girls completing all three HPV shots: study | 05-17-12 |
| South Carolina woman struck by flesh-eating bacteria disease | 05-17-12 |
| Canada OKs Osiris drug; first stem cell therapy | 05-17-12 |
| Breastfed babies may gain less weight | 05-17-12 |
| Sequenom says Coventry cancels test coverage | 05-17-12 |
| FDA OKs multiple companies to sell generic Plavix | 05-17-12 |
| Safety inspections don't hurt businesses-study | 05-17-12 |
| Study unpicks gene changes behind breast cancer | 05-17-12 |
| Alkermes takes bigger 4Q loss after Elan deal | 05-17-12 |
| Sex, age may affect athletes' concussion recovery | 05-17-12 |
| Many pregnant women may not get STD tests | 05-17-12 |
| Specialty drug costs a major employer worry: survey | 05-17-12 |
| Patients should consult before stopping Pfizer drug-FDA | 05-17-12 |
| Prestige Brands posts small fiscal 4Q loss | 05-17-12 |
| Human Genome adopts rights plan to ward off Glaxo | 05-17-12 |
| Novartis lung drug superior to placebo over 1 year | 05-17-12 |
| FDA warning hurts Hikma generics margins | 05-17-12 |
| U.S. lowers threshold for lead poisoning in children | 05-17-12 |
| Data suggests drug treatment can lower U.S. crime | 05-17-12 |
| FCC chooses spectrum for wireless medical devices | 05-17-12 |
| Glaxo melanoma drug combo shows promise in small trial | 05-16-12 |
| Array shares rise on lung cancer, melanoma results | 05-16-12 |
| Study suggests lower death risk for coffee lovers | 05-17-12 |
| Study suggests lower risk of death for coffee lovers | 05-16-12 |
| Allscripts names 2 new directors to board | 05-16-12 |
| Pfizer drug effective in rare children's cancers | 05-16-12 |
| Roche melanoma drug extends life more than a yr-study | 05-16-12 |
| J&J drug shows promise in high-risk prostate cancer | 05-16-12 |
| Aveo kidney cancer drug more tolerated than Nexavar | 05-16-12 |
| Minor, repeat head blows may impair athletes' learning | 05-16-12 |
| U.S. sets deadline for proposals on state healthcare exchanges | 05-16-12 |
| Antibiotic linked with rare but deadly heart risk | 05-16-12 |
| Paralyzed woman uses thoughts to move robotic arm | 05-16-12 |
| Medtronic says bone graft investigation is over | 05-16-12 |
| OraSure surges on recommendation for HIV test | 05-16-12 |
| Revealing brain damage from battlefield to playing field | 05-16-12 |
| Steroids cut sinus infection symptoms slightly | 05-16-12 |
| Back pain tends to improve quickly, not completely | 05-16-12 |
| U.S. HIV aid has prevented 741,000 deaths: study | 05-16-12 |
| Protestors disrupt WellPoint annual meeting | 05-16-12 |
| Arena Pharma says it will sell 11M shares of stock | 05-16-12 |
| India's Piramal to buy US healthcare company | 05-16-12 |
| WHO warns of high blood pressure, diabetes, obesity | 05-16-12 |
| India's Piramal Healthcare to buy U.S. firm to boost R&D | 05-16-12 |
| Buffett's firm buys 10M share stake in GM | 05-15-12 |
| News Summary: Berkshire buys 10M-share stake in GM | 05-16-12 |
| Britain to fund prostate cancer pill in U-turn | 05-15-12 |
| St Jude is latest to launch blood pressure device | 05-15-12 |
| Activist firm takes $600 million stake in PepsiCo | 05-15-12 |
| Sector Wrap: Gentiva rises on home health upgrades | 05-15-12 |
| Buffett's firm buys GM stake, boosts IBM position | 05-15-12 |
| FDA panel backs OraSure's In-Home HIV test | 05-15-12 |
| Cepheid shares rise on UBS analyst's upgrade | 05-15-12 |
| FDA delays deadline for new U.S. sunscreen labels | 05-15-12 |
| Acupuncture may help some people with COPD: study | 05-15-12 |
| News Summary: Cardinal Health resolves DEA claim | 05-15-12 |
| Young adults with autism lag in school, work | 05-15-12 |
| Roche Alzheimer's drug picked for major test | 05-15-12 |
| Romney Medicare Plan Draws a Stark Contrast | 05-15-12 |
| Walgreen adds benefits to customer savings club | 05-15-12 |
| Retiree Money Scams Flourish, Change With the Times | 05-15-12 |
| Cardinal facility suspended under DEA settlement | 05-15-12 |
| Cowher joins campaign to educate about melanoma | 05-15-12 |
| Cardinal Health ends DEA inquiry with settlement | 05-15-12 |
| Insecticide resistance threatens malaria fight | 05-15-12 |
| Achillion's hepatitis C drug gets FDA fast track | 05-15-12 |
| UK lawmakers urge action on medicine shortages | 05-15-12 |
| U.S. launches ambitious Alzheimer's plan with research push | 05-15-12 |
| Almost one in three in U.S. have sleepwalked: study | 05-15-12 |
| OSHA probing former Florida postal worker's illness claims | 05-15-12 |
| Zogenix takes smaller 1Q loss as sales pick up | 05-14-12 |
| Accretive Health shares rise after it denies Minnesota allegations | 05-14-12 |
| Almost 1 in 3 in U.S. have sleepwalked: study | 05-14-12 |
| Avon, Ancestry.com, Ventrus are market movers | 05-14-12 |
| Colon cancer test may not require laxatives: study | 05-14-12 |
| Sector Wrap: Moody's on health care dividends | 05-14-12 |
| FDA says unsure if Novartis MS pill caused deaths | 05-14-12 |
| Ventrus rises on trial of anal fissure treatment | 05-14-12 |
| Marijuana may ease multiple sclerosis symptoms | 05-14-12 |
| Lundbeck says data supports H2 anti-depressant filing | 05-14-12 |
| French drugmaker on trial over weight-loss pill | 05-14-12 |
| More batteries to blame for kids' ER visits | 05-14-12 |
| Analysis: Health by numbers: A statistician's challenge | 05-14-12 |
| Surf's up in the fitness studio | 05-14-12 |
| Analysis: Beleaguered beef purveyors carve out "pink slime" stain | 05-14-12 |
| Analysis: Athletes' sudden deaths expose big knowledge gaps | 05-14-12 |
| Factbox: Soccer player deaths since 1990 | 05-14-12 |
| Osiris Therapeutics rises following 1Q results | 05-11-12 |
| Is Europe a safe place to buy? Not exactly | 05-11-12 |
| FDA panel recommends Gilead's Quad for HIV | 05-11-12 |
| JPMorgan, Nordstrom, Roundy's are market movers | 05-11-12 |
| Implants may help prevent repeat teen pregnancies | 05-11-12 |
| Prenatal smoking tied to worse asthma in kids | 05-11-12 |
| News Summary: Express Scripts details 1Q growth | 05-11-12 |
| Express Scripts stock rises after 1Q growth report | 05-11-12 |
| Industry defends ingredient critics deride as 'meat glue' | 05-11-12 |
| Alzheimer's research fraud case set for trial | 05-11-12 |
| Birth defects linked to childhood cancer: study | 05-11-12 |
| Insight: America's hatred of fat hurts obesity fight | 05-11-12 |
| AmerisourceBergen makes Guttman permanent CFO | 05-11-12 |
| After abuse investigation, kids often remain at risk | 05-11-12 |
| Ahead of the Bell: Gilead 'Quad' pill faces review | 05-11-12 |
| India to probe alleged irregularities within drug regulator | 05-11-12 |
| India to probe alleged irregularities at drug regulator | 05-11-12 |
| India Drugs Inquiry Could Prompt New US Scrutiny | 05-11-12 |
| Blood test may help identify kids' smoke exposure: study | 05-11-12 |
| Is Shy Bladder Syndrome a Disability? | 05-10-12 |
| Industry defends ingredient critics deride as "meat glue" | 05-11-12 |
| FDA panel backs Gilead's Truvada to prevent HIV | 05-11-12 |
| Arena obesity pill wins over U.S. advisers | 05-10-12 |
| Fish tied to lower colon cancer risk: study | 05-10-12 |
| Express Scripts 1Q profit slips 18 percent | 05-10-12 |
| Many kids exposed to smoke despite parents' claims | 05-10-12 |
| MannKind falls on potential delay in Afrezza study | 05-10-12 |
| Amag Pharma falls after ending sale talks | 05-10-12 |
| AmerisourceBergen approves new $750M buyback | 05-10-12 |
| Stop the Mutiny! Keep Employees From Quitting | 05-10-12 |
| Medicare billing flagged at 4 percent of U.S. pharmacies: government | 05-10-12 |
| Psychiatrists say diagnosis manual needs overhaul | 05-10-12 |
| FDA warns MS patients about risky treatment | 05-10-12 |
| Minors have an easy time buying alcohol online | 05-10-12 |
| High-level trauma care may limit disability | 05-10-12 |
| Johnson & Johnson Remains Too Big to Succeed | 05-10-12 |
| Experts unconvinced by changes to psychiatric guide | 05-10-12 |
| PSS World plans strategic shift after weak 4Q | 05-10-12 |
| FDA warns MS patients about risky stent treatment | 05-10-12 |
| US stocks gain on unemployment report | 05-10-12 |
| Cameron Health's under-skin ICD safe, effective | 05-10-12 |
| GSK starts $2.6 bln tender offer for Human Genome | 05-10-12 |
| Industries represented in the Dow average | 05-10-12 |
| Coty boosts buyout bid for Avon to about $10.7B | 05-10-12 |
| GSK starts $2.6 billion tender offer for Human Genome | 05-10-12 |
| Novartis to probe Indian drug approval allegations | 05-10-12 |
| Novartis eye drug efficient over longer term: studies | 05-10-12 |
| Glaxo needs slight sweetener to Human Genome bid: analysts | 05-09-12 |
| Anti-obesity program doesn't help teen girls: study | 05-09-12 |
| GSK goes hostile with $2.6 billion Human Genome offer | 05-09-12 |
| World disease fund gets added $1.6 billion shot in arm | 05-09-12 |
| Deep belly fat may increase after liposuction | 05-09-12 |
| Two proposed changes dropped from psychiatric guide | 05-09-12 |
| Kids' TV time tied to unhealthy food choices | 05-09-12 |
| Senate probes painkiller makers, allied groups | 05-09-12 |
| U.S. may speed approval of "breakthrough" drugs | 05-09-12 |
| U.S. government urged to fight fat at school | 05-09-12 |
| U.S. FDA advisers back Pfizer arthritis drug | 05-09-12 |
| Does everyone with chest pain need a stress test? | 05-09-12 |
| Probe finds collusion between India's drug regulator, pharma firms | 05-09-12 |
| U.S. may speed approval of 'breakthrough' drugs | 05-09-12 |
| Savient's loss widens on higher Krystexxa costs | 05-09-12 |
| GSK to go hostile with $2.6 bln Human Genome tender | 05-09-12 |
| GSK to go hostile with $2.6 billion Human Genome tender | 05-09-12 |
| Health-Care Costs in Retirement Rise to $240,000 | 05-09-12 |
| Gilead's Quad HIV pill appears to be effective-FDA staff | 05-09-12 |
| GlaxoSmithKline in takeover bid for Human Genome | 05-09-12 |
| Merck KGaA's Erbitux fails in colon cancer study | 05-09-12 |
| GSK to launch $2.6 billion Human Genome tender offer | 05-09-12 |
| Teva profit beats forecasts on U.S. drug sales | 05-09-12 |
| Probe uncovers serious problems with India's drug regulator | 05-09-12 |
| Germany's Bayer considers diabetes device unit sale: report | 05-09-12 |
| Obesity fight must shift from personal blame: panel | 05-09-12 |
| Nonprofit hospitals to do more with less: Moodys | 05-09-12 |
| Perrigo 3Q profit up, outlook raised | 05-08-12 |
| "Pink slime" may force BPI corporate staff cuts | 05-08-12 |
| Speaker Boehner's Solutions, Pt. 1 | 05-08-12 |
| Movers roundup: Mako Surgical, Cognizant | 05-08-12 |
| Regeneron: FDA panel says no to Arcalyst for gout | 05-08-12 |
| Earnings roundup: Disney, Curis | 05-08-12 |
| GTx up on clearance for new Capesaris trials | 05-08-12 |
| Health group attacks Gatorade's Michael Jordan ad | 05-08-12 |
| Hate Obamacare? Keep Tax Cuts? You Do the Budget | 05-08-12 |
| Long commutes may be bad for health: study | 05-08-12 |
| Many drug labels missing dose, safety info for kids | 05-08-12 |
| Mako Surgical tumbles on 1Q results, Rio outlook | 05-08-12 |
| Bipolar symptoms may begin in teen years | 05-08-12 |
| FDA advisers rebuff Regeneron gout drug | 05-08-12 |
| Device might spark memories in some with Alzheimer's | 05-08-12 |
| Probiotics may help prevent diarrhea: report | 05-08-12 |
| Henry Schein 1Q profit rises on strong demand | 05-08-12 |
| Avanir takes bigger loss on Nuedexta sales costs | 05-08-12 |
| FDA staff: Gilead's Truvada may help reduce HIV risk | 05-08-12 |
| Nebraska to get nearly $5M in Abbott settlements | 05-08-12 |
| Home Health Care Is One of the Most Profitable Franchises | 05-08-12 |
| Idaho getting $1.2 million in Abbott settlement | 05-08-12 |
| FDA favors first drug for HIV prevention | 05-08-12 |
| Utah receiving $4 million in drug settlement | 05-08-12 |
| FDA revisits safety of Arena Pharma's diet pill | 05-08-12 |
| Ohio to get $14.5 million in Abbott settlements | 05-08-12 |
| Wash. to get $7 million in Abbott settlement | 05-08-12 |
| Iowa will get $1.4 million in Abbott settlement | 05-08-12 |
| Long commutes may be bad for health - study | 05-08-12 |
| FDA staff: Gilead's Truvada may help prevent HIV infection | 05-08-12 |
| Dendreon shares fall after 1Q earnings report | 05-08-12 |
| Obesity fight must shift from personal blame-U.S. panel | 05-08-12 |
| Par Pharma 1st-quarter beats estimates | 05-08-12 |
| Isis Pharma 1Q loss widens as expenses climb | 05-08-12 |
| Obesity fight must shift from personal blame: U.S. panel | 05-08-12 |
| US FDA staff focus on safety of Arena obesity pill | 05-08-12 |
| Possible Overhaul of Military Retirement System Stirs Fear | 05-08-12 |
| CNBC Poll: Should Age for Social Security Benefits Be Raised Again? | 05-08-12 |
| Actelion sees no earnings growth until 2014 | 05-08-12 |
| Allergen receives subpoena over its anti-obesity device | 05-08-12 |
| Intercell signs finance deal with BB Biotech | 05-08-12 |
| Actelion sees return to growth in 2014 | 05-08-12 |
| "Pink slime" label forces beef plant closures | 05-08-12 |
| Maker of "pink slime" to shut 3 plants: Iowa Governor | 05-08-12 |
| Summary Box: Hoped-for cholesterol drug scrapped | 05-07-12 |
| U.S. healthcare access to erode if law struck down: study | 05-07-12 |
| Healthcare access to erode if law struck down: study | 05-07-12 |
| One in eight teens misuses prescription painkillers | 05-07-12 |
| Ask women about partner violence, panel says | 05-07-12 |
| Talk to teens, young adults about sun safety: panel | 05-07-12 |
| Roche scraps hoped-for cholesterol blockbuster | 05-07-12 |
| RI to get more than $2.3M in Depakote settlements | 05-07-12 |
| Abbott to Pay $1.6 Billion in Criminal Sales Settlement | 05-07-12 |
| Court reverses itself on veterans healthcare overhaul | 05-07-12 |
| Dog food salmonella recall expanded in U.S., Canada | 05-07-12 |
| Ahead of the Bell: Vertex Pharma shares jump | 05-07-12 |
| The Inflation of Life ? Cost of Raising a Child Has Soared | 05-07-12 |
| How to Provide for the Kids Post-Divorce | 05-07-12 |
| FDA staff question Pfizer arthritis drug benefits | 05-07-12 |
| US Supreme Court Ruling Key to Cigna Trade | 05-07-12 |
| Roche stops heart drug trial as data disappoints | 05-07-12 |
| Asia stocks dive after Europe elections, US data | 05-07-12 |
| Novartis study positive for new acromegaly therapy | 05-07-12 |
| Factbox: Drugmakers on the cusp of new immunotherapy era | 05-07-12 |
| Insight: Training immune system to fight cancer comes of age | 05-07-12 |
| Roche stops heart drug trial as data disappoint | 05-07-12 |
| Want to quit smoking ? Try acupuncture or hypnosis | 05-07-12 |
| Salmonella linked to dog food, sickens at least 14 people | 05-05-12 |
| Arizona bans funding to Planned Parenthood in abortion fight | 05-05-12 |
| Idaho infant dies from whooping cough amid regional outbreak | 05-05-12 |
| Arizona surgeons carry out rare mom-to-child liver transplant | 05-05-12 |
| Review finds Chantix may not raise heart risks | 05-04-12 |
| Fewer jobs means more spending on U.S. Medicaid | 05-04-12 |
| Amish farm kids remarkably immune to allergies: study | 05-04-12 |
| Some support for quit-smoking alternatives | 05-04-12 |
| Warner Chilcott turns 1Q profit as costs fall | 05-04-12 |
| Aetna completes $750 million bond offering | 05-04-12 |
| Some ob-gyns cite religious conflicts over care | 05-04-12 |
| Pfizer halts late-stage study into new Lyrica use | 05-04-12 |
| Pfizer's Lyrica falls short in two pain studies | 05-04-12 |
| Sirona Dental fiscal 2Q profit rises 4 percent | 05-04-12 |
| FDA staff question side effects of Regeneron gout drug | 05-04-12 |
| FDA staff question studies for Regeneron gout drug | 05-04-12 |
| Cigna CEO Talks Earnings | 05-04-12 |
| Preview: U.S. panel seen backing Pfizer's arthritis drug hope | 05-04-12 |
| Washington state on track for major pertussis epidemic | 05-04-12 |
| Avon shares close up on report of takeover bid | 05-03-12 |
| FDA says number of new drug shortages down | 05-03-12 |
| CareFusion 3Q profit falls on sale of Nicolet unit | 05-03-12 |
| Even at higher genetic heart risk, lifestyle helps | 05-03-12 |
| NIH, companies aim to teach old drugs new tricks | 05-03-12 |
| Catalyst Health 1st-qtr earnings fall 5 percent | 05-03-12 |
| After IVF, some couples get pregnant without help | 05-03-12 |
| SXC Health 1Q profit climbs on PBM, IT strength | 05-03-12 |
| Health Net shares sink after insurer cuts forecast | 05-03-12 |
| Best face forward: chin implants surge in popularity | 05-03-12 |
| Feds: Arrests made in $80M prescription drug heist | 05-03-12 |
| Triplets fare well as teenagers: study | 05-03-12 |
| U.S. to partner with Big Pharma for drug discovery | 05-03-12 |
| Key revenue figure drops 6.4 pct for Walgreen | 05-03-12 |
| DSM to buy Kensey Nash for $360 million | 05-03-12 |
| Vitamins E, C no help against vision disorder | 05-03-12 |
| Cardinal Health fiscal 3Q profit jumps 36 percent | 05-03-12 |
| Kensey Nash sells itself for $360 million to DSM | 05-03-12 |
| Cigna 1Q earnings fall 10 pct, 2012 forecast rises | 05-03-12 |
| India's Dr Reddy's gets U.S. nod for osteoporosis drug | 05-03-12 |
| Smith & Nephew's profit rises after restructuring | 05-03-12 |
| World's Biggest McDonald's a Big Ad for Obesity: UK Doctors | 05-03-12 |
| Huge Medicare Fraud Bust! | 05-02-12 |
| Can portfolio theory save lives? | 05-03-12 |
| Deer Antler Spray Company Suing Major League Baseball | 05-02-12 |
| U.S. quarantines two dairies after mad cow case | 05-02-12 |
| Market Opportunities: Health Care & Energy | 05-02-12 |
| Pre-surgery bladder tests often unnecessary: study | 05-02-12 |
| UPMC, Highmark announce contract extension to 2015 | 05-02-12 |
| US charges more than 100 for Medicare fraud schemes | 05-02-12 |
| Feds Crack Down in $452 Million Medicare Fraud Sweep | 05-02-12 |
| WebMD shares slip on 1Q loss and 2Q forecast | 05-02-12 |
| U.S. charges more than 100 over Medicare fraud schemes | 05-02-12 |
| Amerigroup 1Q profit sinks 53 pct, tops forecasts | 05-02-12 |
| Insurer WellCare's 1Q earnings soar, premiums rise | 05-02-12 |
| U.S. charges more than 100 for Medicare fraud schemes | 05-02-12 |
| Summary Box: CVS Caremark 1Q profit jumps 9 pct | 05-02-12 |
| Johnson & Johnson seeks new approval of Xarelto | 05-02-12 |
| NC's Blue Cross fights lawsuit over pricing power | 05-02-12 |
| US futures fall on weak jobs data in US, Europe | 05-02-12 |
| US Is Coming Off Stimulus Induced High | 05-01-12 |
| Georgia bans most late-terms abortions, assisted suicide | 05-02-12 |
| Overview of 1Q sales trends for Pfizer medicines | 05-01-12 |
| Summary Box: Charges, generics cut Pfizer 1Q net | 05-01-12 |
| FDA approves Protalix's Gaucher drug Elelyso | 05-01-12 |
| Bristol shareholders reject PETA animal proposal | 05-01-12 |
| U.S. Medicare to cover Edwards Sapien heart valve | 05-01-12 |
| Facebook calls on members to flag organ donor status | 05-01-12 |
| Impax Labs falls on weak sales, new FDA warning | 05-01-12 |
| Endo Pharma turns 1Q loss on $100M pre-tax charge | 05-01-12 |
| Summary Box: Avon 1Q results slide 82 percent | 05-01-12 |
| Sharing-for-Cash: A New Way to Finance Retirement | 05-01-12 |
| AmerisourceBergen buys World Courier for $520M | 05-01-12 |
| CNBC Poll: Should Social Security Be Privatized? | 05-01-12 |
| Thermo Fisher buys specialty chemicals maker | 05-01-12 |
| Hospira 1Q profit plummets 73 pct as costs jump | 05-01-12 |
| ViroPharma 1Q profit sinks 45 pct as costs climb | 05-01-12 |
| Avon Products 1Q profit tumbles | 05-01-12 |
| Pfizer Earnings Fall as Lipitor Sales Weaken; Shares Fall | 05-01-12 |
| Pfizer Q1 profit falls 19 pct on generic Lipitor | 05-01-12 |
| Pfizer Profit Slightly Beats, but Shares Fall Pre-Market | 05-01-12 |
| Insight: Cancer in Africa: Fighting a nameless enemy | 05-01-12 |
| Football knee injuries more likely on artificial turf: study | 05-01-12 |
| McKesson 4Q profit jumps 23 percent | 04-30-12 |
| Molina Healthcare 1Q profit edges up 4 percent | 04-30-12 |
| Summary Box: Stocks slip as Spain hits recession | 04-30-12 |
| On the Call: Humana COO James Murray | 04-30-12 |
| Idenix Pharmaceuticals rises on analyst upgrade | 04-30-12 |
| Kilburg's Take on the Markets | 04-30-12 |
| Summary Box: Hologic to buy Gen-Probe for $3.72B | 04-30-12 |
| Buy Stocks in May? | 04-30-12 |
| Alere takes 1Q loss on Axis-Shield purchase costs | 04-30-12 |
| Warner Chilcott in early talks to sell company | 04-30-12 |
| MannKind licenses drugs to Tolero for up to $130M | 04-30-12 |
| Start Up Hopes to Put Drug Test at Companies' Fingertips | 04-30-12 |
| Humana reports 21 percent drop in 1Q profit | 04-30-12 |
| Hologic to Buy Gen-Probe for $3.75 Billion | 04-30-12 |
| Teva, Mylan settle litigation over drug Nuvigil | 04-30-12 |
| Hologic to buy Gen-Probe for about $3.72B | 04-30-12 |
| Costs Soaring as the US Gets Fatter | 04-30-12 |
| Factbox: Obesity's dollars and cents | 04-30-12 |
| As America's waistline expands, costs soar | 04-30-12 |
| Checking up on your fitness form | 04-30-12 |
| Warner Chilcott weighs sale, other options: report | 04-30-12 |
| Pall Corp selling some blood transfusion assets | 04-29-12 |
| In Hopeful Sign, Health Spending Is Flattening Out | 04-29-12 |
| FDA approves antibiotic to treat, prevent plague | 04-28-12 |
| Republicans insert healthcare into student loan fight | 04-27-12 |
| FDA approves Vivus ED drug Stendra | 04-27-12 |
| Abaxis reports 38 percent jump in net income | 04-27-12 |
| MGIC's CEO, 4 others re-elected as directors | 04-27-12 |
| U.S. Republicans insert healthcare into student loan fight | 04-27-12 |
| Goldman Sachs Insider Trading Probe | 04-27-12 |
| New Service Takes the Wait Out of Health Care | 04-27-12 |
| The ZocDoc CEO on Instant Appointments | 04-27-12 |
| Allscripts Shares Plunge on Weak Outlook, Board Changes | 04-27-12 |
| Stocks are flat on Wall Street; Amazon surges | 04-27-12 |
| ImmunoGen fiscal 3Q loss widens as expenses rise | 04-27-12 |
| Supreme Court Moves to Center of Presidential Race | 04-27-12 |
| Small Biz Group Advocates Alternatives to Obama Health Care Plan | 04-27-12 |
| Merck posts big Q1 profit jump on lower charges | 04-27-12 |
| Sanofi confirms weak outlook despite Q1 earns rise | 04-27-12 |
| US Equities Higher on Earnings, Not Operation Twist | 04-26-12 |
| McKesson settles federal false-claim allegations | 04-26-12 |
| Shire 1Q profit grows as ADHD drug sales rise | 04-26-12 |
| Summary Box: Aetna's 1Q profit tumbles 13 percent | 04-26-12 |
| Celgene slips as 1Q results fall short of views | 04-26-12 |
| Zimmer 1Q profit up slightly, meets expectations | 04-26-12 |
| Bristol-Myers 1Q profit up 12 pct. as sales rise | 04-26-12 |
| Amylin takes bigger 1Q loss after Lilly deal ends | 04-26-12 |
| Insurer Aetna's 1Q profit tumbles 13 percent | 04-26-12 |
| Health insurers to pay $1.3 billion in rebates: study | 04-26-12 |
| Johnson & Johnson boosts dividend by 7 percent | 04-26-12 |
| Upbeat US housing figures shore up markets | 04-26-12 |
| Health insurers to pay $1.3 billion in rebates, study finds | 04-26-12 |
| Bristol-Myers Q1 profit up 12 pct. as sales rise | 04-26-12 |
| AstraZeneca CEO quits as drug sales tumble | 04-26-12 |
| Indonesia suspends some U.S. beef imports on mad cow | 04-26-12 |
| Buyers of U.S. beef keep importing after mad cow case | 04-26-12 |
| South Korea GDP Picks Up but Doubts Remain About Future | 04-26-12 |
| J&J CEO: Need to Get Recalled Items Back on Shelves | 04-25-12 |
| Summary Box: New J&J CEO takes reins Thursday | 04-25-12 |
| New J&J CEO plans realistic, optimistic future | 04-25-12 |
| Acorda says MS drug benefits lasted up to 5 years | 04-25-12 |
| Human Genome Sciences takes smaller 1Q loss | 04-25-12 |
| Insurer WellPoint's 1Q profit falls as costs climb | 04-25-12 |
| Edwards Lifesciences jumps on 1Q results, outlook | 04-25-12 |
| FDA extends review of Salix, Progenics drug | 04-25-12 |
| US mad cow case won't affect trade with Canada | 04-25-12 |
| Debt Collector Is Faulted for Tough Tactics in Hospitals | 04-25-12 |
| GlaxoSmithKline shares drop on Q1 disappointment | 04-25-12 |
| Thermo Fisher 1Q results top Street, ups outlook | 04-25-12 |
| GlaxoSmithKline Q1 profit down 13 pct | 04-25-12 |
| Mad cow disease found in California; no human threat seen | 04-25-12 |
| EU says no impact on U.S. beef imports from mad cow case | 04-25-12 |
| Eli Lilly's CEO on Prescription for Profits | 04-25-12 |
| Russia may answer U.S. mad cow outbreak with limits | 04-25-12 |
| Factbox: Mad Cow and Creutzfeldt-Jakob disease | 04-25-12 |
| Eli Lilly Revenue, Profit Beat Forecasts | 04-25-12 |
| Amgen buying Turkey's Mustafa Nevzat for $700M | 04-25-12 |
| South Korean Retailers Halt US Beef Sales | 04-25-12 |
| Top vet rushes to soothe mad cow fears | 04-25-12 |
| Summary Box: Sales, profit both up in Q1 for Amgen | 04-24-12 |
| Mexico to maintain US beef trade after mad cow case | 04-24-12 |
| U.S. beef, dairy in food supply safe: USDA secretary | 04-24-12 |
| Edwards Lifesciences 1Q profit edges higher | 04-24-12 |
| CR Bard 1Q profit rises 5 percent as sales improve | 04-24-12 |
| Mexico to maintain U.S. beef trade after mad cow case | 04-24-12 |
| Factbox: Mad cow cases in U.S. and Canada | 04-24-12 |
| INSTANT VIEW 10-Mad cow disease found in California | 04-24-12 |
| Mad cow disease found in California dairy cow: USDA | 04-24-12 |
| Mad cow disease found in California; USDA says no human threat | 04-24-12 |
| Instant View: Mad cow disease found in California | 04-24-12 |
| JBS confident US beef exports will not be hurt | 04-24-12 |
| USDA holding press briefing as mad cow rumor roils market | 04-24-12 |
| USDA confirms case of mad cow disease, nation's fourth | 04-24-12 |
| 'Mad Cow' Disease Found in California: USDA | 04-24-12 |
| Movers roundup: Netflix, Sequenom | 04-24-12 |
